Received May 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | UNK | 945665 | — |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2345B | — |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y3Z9P | — |
Vasovagal reaction Patient did experience a vasovagal response after receiving immunizations. No LOC. Still conscious, alert to stimuli. She was placed in supine position with feet elevated, cool towels applied to forehead. Initial vital signs on evaluation included diaphoresis, alert, blood pressure 120/100, heart rate 58. O2 98. Patient was given apple juice, we were at bedside. No syncopal. Patient's blood pressure on discharge was 111/75, heart rate 89. Verbalized this has happened in the past.
None
Generalized anxiety disorder Moderate episode of recurrent major depressive disorder (CMS-HCC) Gender dysphoria Vitamin D deficiency
buPROPion (WELLBUTRIN XL) 150 mg 24 hr tablet Take 1 tablet by mouth every morning. Take with one 300mg tab for a total of 450mg daily. buPROPion (WELLBUTRIN XL) 300 mg 24 hr tablet Take 1 tablet by mouth daily. Take with one 150mg tab for
None
None